Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid.
D000818:Animals; D001929:Brain Edema / Q000517:prevention & control; D002478:Cells, Cultured; D006259:Craniocerebral Trauma / Q000503:physiopathology; D013759:Dronabinol / Q000031:analogs & derivatives* / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D005849:Gerbillinae; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology; D002546:Ischemic Attack, Transient / Q000503:physiopathology; D016202:N-Methylaspartate / Q000633:toxicity; D009474:Neurons / Q000166:cytology* / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009498:Neurotoxins / Q000633:toxicity; D011712:Pyramidal Tracts / Q000187:drug effects / Q000473:pathology; D051381:Rats
D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D009498:Neurotoxins; D016202:N-Methylaspartate; D013759:Dronabinol; C062018:HU 211